openPR Logo
Press release

Insulin Market Size Projected at USD 31.5 Billion by 2035, Boosted by Technological Advancements and Expanding Patient Pool - TMR Report

11-12-2025 03:13 PM CET | Health & Medicine

Press release from: Transparency Market Research Pvt Ltd

/ PR Agency: Transparency Market Research Pvt Ltd
Insulin Market

Insulin Market

Insulin Market Size -

The global Insulin Market was valued at US$ 20.3 billion in 2024 and is projected to expand at a CAGR of 4.1% from 2025 to 2035. By the end of 2035, the market is expected to surpass US$ 31.5 billion, driven by the rising prevalence of diabetes worldwide, increasing demand for advanced insulin delivery devices, and continuous innovations in biosynthetic and long-acting insulin formulations.

📊 Don't miss out on the latest market insights. Get your sample report copy today 👉 Request Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=259

Market Overview -

The Insulin Market comprises the production and distribution of insulin formulations designed for diabetes management. Insulin therapy remains a critical component of diabetes care, especially for patients with type 1 diabetes and advanced type 2 diabetes. The market has evolved significantly over the last decade, transitioning from traditional human insulin to modern analogs and biosimilars that offer enhanced efficacy, reduced side effects, and greater patient convenience.

Growing healthcare awareness, an aging population, and increasing healthcare expenditure across developing economies continue to drive insulin adoption. The integration of digital health technologies and connected insulin delivery devices is further enhancing treatment adherence and patient outcomes globally.

Market Description -

Insulin, a hormone responsible for glucose metabolism, is administered externally to patients with diabetes to maintain optimal blood sugar levels. The market features various types of insulin, including rapid-acting, short-acting, intermediate-acting, long-acting, and premixed formulations.

Pharmaceutical companies are focusing on developing smart insulin pens, insulin pumps, and connected devices that allow real-time glucose tracking and dosage adjustments. Additionally, biosimilar insulin products are gaining prominence due to their cost-effectiveness and increasing regulatory approvals. The growing prevalence of type 2 diabetes, especially in middle- and low-income countries, is expanding the overall insulin demand base.

Analysis of Key Players in the Insulin Market

Leading companies in the global insulin market are increasingly forming partnerships with hospitals, specialty clinics, and research institutes to strengthen their market presence and achieve inorganic growth.

Key players in the industry include
• Shanghai Fosun Pharmaceutical Co., Ltd.
• Tonghua Dongbao
• Eli Lilly and Company
• Sanofi
• Novo Nordisk A/S
• Julphar
• Biocon Ltd.
• Becton, Dickinson, and Company
• Ypsomed AG
• Biodel, Inc.
• B. Braun Melsungen AG
• Other prominent players.

Each of these companies has been profiled in the Insulin Market Research Report based on parameters such as company overview, financial performance, business strategies, product portfolio, business segments, and recent developments.

Key Developments in the Insulin Market

• December 2024: The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma in collaboration with Eli Lilly and Company. Originally launched in 2022, this partnership focuses on ensuring a sustainable supply of high-quality, affordable human and analog insulin to at least one million people annually living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), primarily across Africa.

• June 2024: Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced the launch of an authorized generic version of Victoza® (liraglutide injection 1.8 mg) in the United States, expanding access to cost-effective diabetes treatments.

📌 Detailed strategy mapping is available in the sample report copy - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=259

Key Player Strategies -

• Innovation in Formulations: Developing ultra-long-acting and combination insulin therapies to improve glycemic control and patient compliance.
• Digital Integration: Expanding the use of insulin pens and pumps integrated with glucose monitoring systems and mobile health apps.
• Strategic Partnerships: Collaborating with tech companies and healthcare providers to enhance insulin delivery systems and remote patient monitoring.
• Biosimilar Expansion: Investing in biosimilar insulin production to cater to price-sensitive markets and increase global accessibility.
• Geographic Diversification: Strengthening presence in Asia-Pacific, Latin America, and the Middle East to meet rising diabetes incidence rates.

Challenges -

• High Production Costs: The complex manufacturing process of insulin increases production costs and limits affordability in low-income regions.
• Pricing Pressure: Competitive pricing, government regulations, and reimbursement constraints challenge profitability.
• Cold Chain Requirements: Temperature-sensitive insulin formulations require efficient logistics and cold storage facilities.
• Limited Access in Developing Regions: Despite growing demand, insulin access remains low in rural and resource-poor areas.

Opportunities -

• Rising Prevalence of Diabetes: The global diabetic population surge creates consistent insulin demand.
• Technological Advancements: Adoption of smart insulin delivery systems and AI-enabled glucose monitoring enhances treatment precision.
• Emergence of Biosimilar Insulins: Offers cost-effective alternatives for patients and healthcare systems worldwide.
• Government Health Initiatives: Public healthcare programs supporting diabetes management to boost insulin adoption.
• Homecare Settings: Growing trend toward self-administration and home-based diabetes management solutions.

Market Segmentations -

By Type:
• Rapid-Acting Insulin
• Short-Acting Insulin
• Intermediate-Acting Insulin
• Long-Acting Insulin
• Premixed Insulin

By Source:
• Human Insulin
• Insulin Analogs
• Biosimilar Insulin

By Delivery Device:
• Insulin Pens
• Insulin Pumps
• Syringes & Vials
• Jet Injectors

By Indication:
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:
• North America: Dominates due to high diabetes prevalence, advanced healthcare systems, and strong presence of key players.
• Europe: Significant market share owing to government reimbursement policies and innovative treatment options.
• Asia-Pacific: Fastest-growing region due to increasing diabetes cases, healthcare expenditure, and biosimilar adoption.
• Latin America & Middle East & Africa: Emerging markets with rising awareness and improving healthcare infrastructure.

📈 To purchase the complete market research report, click here: https://www.transparencymarketresearch.com/checkout.php?rep_id=259<ype=S

Why Buy This Report?

• Comprehensive Insights: Gain a clear understanding of market dynamics, growth drivers, and future outlook.
• Detailed Segment Analysis: Explore insulin types, delivery devices, and regional trends in-depth.
• Competitive Landscape: Examine the strategies of leading global insulin manufacturers.
• Accurate Forecasts: Access reliable market projections for informed business planning.
• Opportunity Mapping: Identify emerging trends such as biosimilar growth and connected device adoption.
• Strategic Guidance: Obtain actionable recommendations to navigate regulatory, pricing, and innovation challenges.

Conclusion -

The Insulin Market is poised for steady growth, driven by the global diabetes burden and technological advancements in drug delivery systems. The shift toward patient-centric care, coupled with the emergence of biosimilars and smart insulin technologies, is reshaping the market landscape. Despite challenges related to pricing and access, leading players continue to innovate and expand into emerging markets, ensuring that insulin remains at the forefront of diabetes management worldwide.

More Trending Research Reports-

• H1N1 Vaccination Market - https://www.transparencymarketresearch.com/h1n1-vaccination-market.html
• Cluster Headache Market - https://www.transparencymarketresearch.com/cluster-headache-market.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Market Size Projected at USD 31.5 Billion by 2035, Boosted by Technological Advancements and Expanding Patient Pool - TMR Report here

News-ID: 4267011 • Views: …

More Releases from Transparency Market Research Pvt Ltd

Pet Dietary Supplements Market Size Expected to Expand at 6.6% CAGR, Hitting US$ 7.4 Billion by 2035 | Affinity Petcare SA (Advance), Elanco, FoodScience, LLC (VetriScience) and more
Pet Dietary Supplements Market Size Expected to Expand at 6.6% CAGR, Hitting US$ …
Pet Dietary Supplements Market Outlook 2035 The global pet dietary supplements market was valued at US$ 3.7 Bn in 2024 and is projected to reach US$ 7.4 Bn by 2035, expanding at a CAGR of 6.6% from 2025 to 2035. Demand for pet supplements continues to surge as pet owners increasingly prioritize preventive healthcare, longevity, immunity, and overall wellness for their pets. Rising pet humanization, premiumization in pet care, and growing…
HVAC Filters Market Size to Grow from US$ 5,350.2 Million in 2024 to US$ 9,326.4 Million by 2035 - Exclusive Report by TMR
HVAC Filters Market Size to Grow from US$ 5,350.2 Million in 2024 to US$ 9,326.4 …
HVAC Filters Market Outlook 2035 The global HVAC filters market was valued at US$ 5,350.2 Mn in 2024 and is projected to reach US$ 9,326.4 Mn by 2035, expanding at a CAGR of 5.2% from 2025 to 2035. Market growth is primarily driven by rising awareness about indoor air quality (IAQ), increasing prevalence of respiratory disorders, expansion of commercial infrastructure, and stringent environmental and filtration standards across industries. The growing demand for…
Roadside Drug Testing Devices Market Size Expected to Surge at 21.2% CAGR, Hitting US$ 19.0 Billion by 2035 | Abbott, Drägerwerk AG & Co. KGaA and more
Roadside Drug Testing Devices Market Size Expected to Surge at 21.2% CAGR, Hitti …
Roadside Drug Testing Devices Market Outlook 2035 The global roadside drug testing devices market was valued at US$ 2.3 billion in 2024 and is projected to reach US$ 19.0 billion by 2035, expanding at an exceptional CAGR of 21.2% from 2025 to 2035. The market is experiencing rapid growth due to rising drug-impaired driving incidents, stringent government regulations, increased law enforcement initiatives, and adoption of advanced portable testing technologies across the…
Lip & Cheek Tint Market Size to Grow from US$ 1.6 Billion in 2024 to US$ 3.2 Billion by 2035 - TMR
Lip & Cheek Tint Market Size to Grow from US$ 1.6 Billion in 2024 to US$ 3.2 Bil …
Lip & Cheek Tint Market Outlook 2035 The global lip & cheek tint market was valued at US$ 1.6 Bn in 2024 and is projected to reach US$ 3.2 Bn by 2035, expanding at a CAGR of 6.5% from 2025 to 2035. Market growth is strongly driven by the expansion of the hybrid and remote work culture, rising corporate workforce population in emerging economies, growing consumer interest in multi-functional cosmetics, and…

All 5 Releases


More Releases for Insulin

Insulin Delivery System Advancement Drives the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR This…
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful…
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful…
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals…
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,…
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin…